(Q57272149)

13

object named as

L. W. M. M. Terstappen

0 references

author name string

T. J. N. Hiltermann

1

0 references

M. M. Pore

2

0 references

A. van den Berg

3

0 references

H. M. Boezen

5

0 references

J. J. W. Liesker

6

0 references

J. H. Schouwink

7

0 references

W. J. A. Wijnands

8

0 references

G. S. M. A. Kerner

9

0 references

F. A. E. Kruyt

10

0 references

H. Tissing

11

0 references

A. G. J. Tibbe

12

0 references

H. J. M. Groen

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database

14

0 references

publication date

11 June 2012

0 references

published in

Annals of Oncology

0 references

volume

23

0 references

issue

11

0 references

page(s)

2937-2942

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Prognostic impact of circulating tumor cells in patients with small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Statistics in respiratory medicine. 2. Repeatability and method comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

A “live” biopsy in a small-cell lung cancer patient by detection of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung ca

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Assessing the measure of a new drug: is survival the only thing that matters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS138